In previous columns, I have examined the evolving trajectory of AI regulation and warned of the precarious path ahead. Regrettably, I must now report that the regulation of artificial intelligence in ...

From target discovery to trial optimization, bfLEAP™ empowers biopharma teams to predict therapeutic success with greater confidence In a $200B+ market crowded with black-box AI, BullFrog AI’s bfLEAP™ ...